MPM Oncology Impact Management »

Edgewise Therapeutics shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $13M 741k 18.01
2024-03-31 $8.0M 441k 18.24
2023-06-30 $5.5M 713k 7.75
2022-09-30 $3.0M 304k 9.84

More positions owned by MPM Oncology Impact Management

Cullinan Therapeutics Common (CGEM)
Insmed Incorporated Common (INSM)
Olema Pharmaceuticals Common (OLMA)
iTeos Therapeutics Common (ITOS)
Crinetics Pharmaceuticals Common (CRNX)
Madrigal Pharmaceuticals Common (MDGL)
Iovance Biotherapeutics Common (IOVA)
Natera Common (NTRA)
Mirum Pharmaceuticals Common (MIRM)
Ultragenyx Pharmaceutical Common (RARE)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Guardant Health Common (GH)
Disc Medicine Common (IRON)
Alkermes Common (ALKS)
Edgewise Therapeutics Common (EWTX)

View all positions for MPM Oncology Impact Management

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
BlackRock
BlackRock
Baker Bros. Advisors
Novo A/S
Vanguard Group
Cormorant Asset Management
Frazier Life Sciences Management
Paradigm Biocapital Advisors
Henderson Group
Perceptive Advisors
TCG Crossover Management
Braidwell
Driehaus Capital Management

View all funds holding Edgewise Therapeutics